SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-22-004954
Filing Date
2022-07-22
Accepted
2022-07-22 07:30:18
Documents
12
Period of Report
2022-07-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_072222.htm   iXBRL 8-K 23634
  Complete submission text file 0001171843-22-004954.txt   196981

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE apto-20220718.xsd EX-101.SCH 2935
3 XBRL LABEL FILE apto-20220718_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE apto-20220718_pre.xml EX-101.PRE 22343
6 EXTRACTED XBRL INSTANCE DOCUMENT f8k_072222_htm.xml XML 3693
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 221098426
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences